Lai, Chih-ChengChih-ChengLaiKo, Wen-ChienWen-ChienKoChen, Chih-JungChih-JungChenChen, Po-YenPo-YenChenHuang, Yhu-CheringYhu-CheringHuangPING-ING LEEPO-REN HSUEH2021-08-162021-08-162021-07-0814760584https://scholars.lib.ntu.edu.tw/handle/123456789/578024To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination.enCOVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia[SDGs]SDG3administration and dosage; adverse event; human; prevention and control; thrombocytopenia; thrombosis; COVID-19; COVID-19 Vaccines; Humans; Thrombocytopenia; Thrombosisreview10.1080/14760584.2021.1949294341764152-s2.0-85110149978https://scholars.lib.ntu.edu.tw/handle/123456789/577866